Taurine is an amino acid found throughout the body and in various foods, and a compound that generated major hype after a 2023 Science paper found taurine supplementation extended lifespan in mice and improved markers of aging in monkeys. Worth being direct: this was one study, in animals, and the human evidence for a longevity effect specifically is currently much thinner than the headlines suggested. Separately, taurine does have a longer, established history of research in cardiovascular health at more modest, well-studied doses, a genuinely different and more solid use case than the one the 2023 headlines were actually about.
- The 2023 Science paper's lifespan and aging-marker findings are animal-only, not yet confirmed in humans.
- The doses used in that mouse study don't have an established, trial-tested human equivalent yet.
- Cardiovascular research has separately used 1.5-3g/day, a distinct, more established use case.
- Generally well-tolerated at studied cardiovascular-research doses.
The 2023 Science paper on taurine deficiency
A 2023 paper published in Science, one of the most prestigious general-science journals, found that taurine levels decline with age and that taurine supplementation extended lifespan in mice and improved several markers of aging in a separate study on monkeys. This is a striking, high-profile finding, published in a top-tier journal and covering multiple animal models, which is part of why it generated such significant public attention when it was released.
The critical, honest caveat is that this remains, as of now, an animal-only finding for the specific claim of extending lifespan. Human trials testing whether taurine supplementation produces an equivalent longevity effect haven't been conducted at the scale needed to confirm the headline claim, and the specific doses used in the mouse study don't have an established, trial-tested human equivalent, unlike the separate cardiovascular research covered below.
Why the taurine decline premise is contested
In 2025 the first half of that paper was directly challenged. Fernandez and colleagues, from Rafael de Cabo’s group at the US National Institute on Aging, used longitudinal data — repeated measurements in the same individuals — across three large human cohorts including the Baltimore Longitudinal Study of Aging, plus rhesus monkeys and mice.
Circulating taurine did not decline with age. Concentrations increased or stayed unchanged in healthy individuals across all three mammalian species. The increase was sex-specific, appearing in every cohort except male mice, where taurine was unchanged.
Variation between individuals at the same age exceeded any age-related change within individuals. Taurine concentrations were inconsistently associated with health outcomes across ages, species and cohorts, and were not associated with muscle mass, strength, physical performance or mitochondrial function.
The authors concluded that changes in circulating taurine are not a universal feature of aging, and that the efficacy of supplementation may be context-dependent.
Be precise about what this does and does not affect. The mouse lifespan experiment still happened and its result stands. What has been undermined is the explanatory story attached to it: that taurine falls progressively with age, creating a deficiency that supplementation reverses. Without that premise the human case is considerably weaker than the 2023 coverage implied, and the species gap is wider than it looked rather than narrower.
The separate cardiovascular research
Distinct from the 2023 longevity headlines, taurine has a longer, separately established history of research in cardiovascular health, using more modest doses in the 1.5-3g/day range. This body of research predates the 2023 paper and rests on its own, separate evidence base, worth treating as a distinct question from whether taurine extends lifespan the way the mouse study suggested.
This is a useful distinction to hold onto, taurine isn't a single, unified evidence story, it's two different research threads, an established, modest cardiovascular use case, and a much newer, exciting, but still animal-only longevity hypothesis, that happen to involve the same compound.
Keeping the two evidence bases apart
Most coverage cites the 2023 Science paper as though it settles the human longevity question. It doesn’t distinguish that work from the separate, more modest cardiovascular research, and the headline claim remains animal-only.
The cardiovascular use has human evidence at a studied dose. The longevity hypothesis has striking animal data and no human confirmation.
Those are two different claims that happen to share a compound. Treating them as one is where most of the confusion in this category comes from.
| 2023 Longevity Study | Cardiovascular Research | |
|---|---|---|
| Species studied | Mice, monkeys | Includes human trials |
| Human dose established | No | Yes, 1.5-3g/day |
| Research history | New, 2023 | Longer-established |
| Outcome studied | Lifespan, aging markers | Cardiovascular markers |
The mouse lifespan result, the contested human decline premise and the separate cardiovascular literature are three different things.
Confusing these two evidence bases, borrowing the excitement of the 2023 animal study to justify a "longevity dose" that hasn't actually been tested in humans, is the single most common misstep in how taurine gets discussed in popular longevity content.
Dosage and timing
Cardiovascular research has used 1.5-3g/day, a dose range with actual human trial support behind it. The doses used in the 2023 mouse longevity study don't have an established, trial-tested human equivalent yet, meaning anyone taking a much higher "longevity dose" based on that study is doing so without confirmed human dosing evidence. No strong timing requirement has been identified in current research.
Safety
Taurine is generally well-tolerated at the studied cardiovascular-research doses, with a reasonably long history of safe use in that specific context. Worth treating any specific "longevity dose" claim with real skepticism until human trials actually catch up to the 2023 mouse findings, taking a much higher dose in hopes of replicating the mouse results isn't currently supported by human safety or efficacy data.
Common misconceptions
"The 2023 study proves taurine extends human lifespan." That finding was in mice and monkeys, a genuinely striking animal result, but not yet confirmed in humans, treating it as settled human evidence significantly overstates where the science currently stands.
"Since taurine has cardiovascular benefits, the longevity claim must be true too." These are separate evidence bases studying different outcomes at different doses, established cardiovascular benefit at 1.5-3g/day doesn't confirm the much newer, animal-only longevity hypothesis from the 2023 paper.
"Taking a very high dose will replicate the mouse study results in me." The mouse study's doses don't have a trial-tested human equivalent, scaling up on your own without established human dosing data is guesswork, not an evidence-backed strategy.
Where taurine fits in a plan
The app separates taurine's established use from its newer, animal-only longevity hype, clearly.
Sources
Key references for the claims on this page. Where a figure is attributed to a specific study or body, it is named here.
- Fernandez MC, et al. Is taurine an aging biomarker? Science. 2025. From Rafael de Cabo’s group at the US National Institute on Aging. Longitudinal data across three human cohorts, rhesus monkeys and mice, directly challenging the age-related decline premise. DOI
- Taurine deficiency as a driver of ageing. Science, 2023. Foundational, and animal-only for the longevity claim.
- The cardiovascular section rests on review literature that is not identified here. No usable reference was available, and the claims in that section should be read accordingly.
Frequently asked
Does taurine extend human lifespan?
This was one study, in animals, the human evidence for a longevity effect specifically is much thinner than the 2023 headlines suggested.
What did the 2023 study actually find?
Taurine extended lifespan in mice and improved aging markers in monkeys, a real animal finding, not yet confirmed in humans.
Is there an established human use for taurine?
Yes, separately from the 2023 headlines, taurine has a longer history of cardiovascular research at 1.5-3g/day.
Is taurine safe to take?
Generally well-tolerated at studied cardiovascular doses, treat any specific "longevity dose" claim with skepticism until human trials catch up.